Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The Purpose of this study is to determine whether Adductor-Canal-Block (ACB) is superior to placebo when it comes to analgetic efficacy after Knee-Arthroscopy.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Adductor-Canal-Block, Ropivacain | Experimental | Adductor-Canal-Block, 30 mL Ropivacain 7,5 mg/mL. Single dose. Ultrasound-guided application. 36 patients |
|
| Adductor-Canal-Block (ACB) - Saline | Placebo Comparator | Adductor-Canal-Block, Placebo (30 mL Saline). Ultrasound-guided application. 36 patients. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Adductor-Canal-Block, Ropivacain | Procedure | Ultrasound-guided ACB; 30 mL Ropivacain 7,5 mg/mL. Single dose. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Pain-Score (VAS) - patient standing | Pain-score messured on a Visual Analog Scale (VAS) 2 hours after adductor canal block. Patient standing. Intervention-group vs. placebo-group. | 2 hours postoperative |
| Measure | Description | Time Frame |
|---|---|---|
| Pain-score (VAS), patient at rest | ACB-group vs. placebo | 0,1,2,4,6,8,24 hours postoperative |
| Pain-score (VAS), patient standing | ACB-group vs. placebo |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Malene Espelund, MD | Glostrup University Hospital, Copenhagen, Denmark | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Anaesthesiology, Glostrup University Hospital | Glostrup Municipality | Copenhagen | 2600 | Denmark |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 24205802 | Derived | Espelund M, Fomsgaard JS, Haraszuk J, Dahl JB, Mathiesen O. The efficacy of adductor canal blockade after minor arthroscopic knee surgery--a randomised controlled trial. Acta Anaesthesiol Scand. 2014 Mar;58(3):273-80. doi: 10.1111/aas.12224. Epub 2013 Nov 8. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010146 | Pain |
| ID | Term |
|---|---|
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D000077212 | Ropivacaine |
| D012965 | Sodium Chloride |
| ID | Term |
|---|---|
| D000813 | Anilides |
| D000577 | Amides |
| D009930 | Organic Chemicals |
| D000814 | Aniline Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Adductor Canal Block, Placebo (saline) | Procedure | Ultrasound-guided Adductor Canal Block; 30 mL Saline. Single dose. |
|
| 1,2,4,6,8,24 hours postoperative |
| Pain-score (VAS), after 5 meters of walk | ACB-group vs. placebo | 2,4,6,8,24 hours postoperative |
| Total Opioid-consumption | ACB-group vs. placebo-group | 0-24 hours postoperative |
| Opioid-consumption, postoperative | i.v. morfin 0-2 hours postoperative tbl. morfin 2-24 hours postoperative ACB vs. placebo | 0-2, 2-4, 4-6, 6-8, 8-24 hours postoperative |
| Postoperative Nausea and vomiting | Rating-scale 0-3 ACB-group vs. placebo-group | 0-1, 1-2, 2-4, 4-6, 6-8, 8-24 hours postoperative |
| Postoperative ondansetron consumption | ACB-group vs. placebo-group | In-hospital |
| Sedation | Rating-scale: 0-3 ACB-group vs. placebo-group | 0,1,2,4,6,8,24 hours postoperative |
| D000588 |
| Amines |
| D002712 | Chlorides |
| D006851 | Hydrochloric Acid |
| D017606 | Chlorine Compounds |
| D007287 | Inorganic Chemicals |
| D017670 | Sodium Compounds |